017 — Winfield, Illinois

017 is a clinical research site located in Winfield, Illinois, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

017 has participated in 2 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Pharma, UCB BIOSCIENCES, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Winfield

Browse all research sites in Illinois · View every site in Winfield

• Central Du Page Hospital
• Northwestern Memorial Hospital
• Cadence Health, Northwestern Medicine Central DuPage Hospital
• Central DuPage Hospital
• Northwestern Medicine - Central DuPage Hospital - Infectious Disease
• Central DuPage Hospital, Northwestern Medicine
• Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center
• Robert H. Lurie Comprehensive Cancer Center of Northwestern University,25 N Winfield Road
• Centra Dupage Hospital
• Central DuPage Hospital Association d/b/a Northwestern Medicine Central DuPage Hospital
• Loyola Cancer Care & Research Ctr. at Central Dupage Hospital
• Central DuPage Hospital Association

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 017?

017 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 017 conducted?

017 has 2 clinical trials on record. Their work covers Epilepsy.

Is 017 accredited by Crixeo Clinical Trials?

017 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 017?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.